MD, FRCPC, CSPQ
With this special issue of the Journal of Current Clinical Care we aim to provide community healthcare professionals with practical clinical insight and support in managing patients with ulcerative colitis.
Informed patients are one of the most important assets available in the management of patients with ulcerative colitis.
5-Aminosalicylates (5-ASAs) are considered first-line therapy for mild to moderate ulcerative colitis because of their proven effectiveness and safety profile, even in pregnancy.
MD, MS, FRCPC
A 28-year-old male presented to our office for a consultation about his bloody bowel movements. Colonoscopy revealed moderately active left-sided ulcerative colitis extending from the anal verge up to the mid-descending colon.
Optimizing Targets in Patient Management of Ulcerative Colitis: The Role of Fecal Calprotectin in Guiding Maintenance TherapyMD
Although medical therapy for ulcerative colitis is usually effective at inducing clinical remission, numerous studies have shown that patients in clinical remission may have ongoing and varying degrees of mucosal inflammation.
From time-to-time we select a topic and present the information and facts in an exciting and visually informative format.
MD, CCFP, FRCPC
MD, CCFP, ABFM
As the population is aging, physicians from all specialties are expected to see more older adults at their outpatient practices and in the acute settings.
Dyspepsia is defined as an epigastric pain or discomfort thought to originate in the upper gastrointestinal (GI) tract.
Low-dose acetylsalicylic acid (ASA) is widely used in the prevention of cardiovascular events but can be associated with upper gastrointestinal (GI) complications, including ulcers.
Optimizing Targets in Patient Management of Ulcerative Colitis: The Role of Fecal Calprotectin in Guiding Maintenance Therapy